1. Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men

   • B. Bengtsson-Hasselgren
   • O. Rönn
   • S. Raner

   Originals Pages: 529 - 533

2. Betaxolol: a pilot study of its pharmacological and therapeutic properties in pregnancy

   • M. J. Boutroy
   • P. L. Morselli
   • A. Zipfel

   Originals Pages: 535 - 539

3. Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers

   • I. Pörsti
   • P. Arvola
   • H. Vapaatalo

   Originals Pages: 541 - 546

4. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam

   • C. Benveniste
   • R. Striberni
   • P. Dayer

   Originals Pages: 547 - 549

5. Effect of the antidepressant Org 3770 on human sleep

   • G. S. F. Ruigt
   • B. Kemp
   • H. A. C. Kamphuisen

   Originals Pages: 551 - 554

6. The effect of ketoconazole and transdermal estradiol on serum sex steroid hormones levels

   • G. S. Hughes
   • S. F. Francom
   • T. V. Ringer

   Originals Pages: 555 - 560

7. Dynamics of drug regimen compliance — its assessment by microprocessor-based monitoring

   • W. Kruse
   • E. Weber

   Originals Pages: 561 - 565

8. The effect of dietary energy and protein deficiency on drug metabolism

   • O. Hamberg
   • L. Ovesen
   • J. Sonne

   Originals Pages: 567 - 570

9. Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects — a comparison with atenolol

   • E. S. Dimenäs
   • C. G. Dahlöf
   • P. W. Lücker

   Originals Pages: 571 - 578

10. The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers

    • J. M. Poirier
    • P. Jaillon
    • G. Cheymol

    Originals Pages: 579 - 582

11. Metabolism of the diuretic bumetanide in healthy subjects and patients with renal impairment

    • M. R. Howlett
    • G. G. Skellern
    • W. R. Murdoch

    Originals Pages: 583 - 586

12. Single- and multiple-dose pharmacokinetics of R-(−)- and S-(+)-prenylamine in man

    • Y. Gietl
    • H. Spahn
    • E. Mutschler

    Originals Pages: 587 - 593

13. Absorption kinetics of oral and rectal flecainide in healthy subjects

    • L. Lie-A-Huen
    • J. H. Proost
    • D. K. F. Meijer

    Originals Pages: 595 - 598

14. Pharmacokinetics of isradipine in patients with chronic liver disease

    • J. Cotting
    • J. Reichen
    • E. Nüesch

    Originals Pages: 599 - 603

15. Albendazole kinetics in patients with echinococcosis: Delayed absorption and impaired elimination in cholestasis

    • J. Cotting
    • T. Zeugin
    • J. Reichen

    Originals Pages: 605 - 608

16. Pharmacokinetics and endocrine effects of terguride in healthy subjects

    • W. Krause
    • H. Träger
    • R. Dorow

    Originals Pages: 609 - 615

17. Metamizole: reassessment of its therapeutic role

    • F. Arellano
    • J. A. Sacristán

    Short Communications Pages: 617 - 619

18. Relative absorption of the two enantiomers of terbutaline after duodenal administration

    • L. Borgström
    • B. -M. Kennedy
    • B. Angelin

    Short Communications Pages: 621 - 623

19. High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects

    • P. V. Luoma
    • A. Rautio
    • J. Marniemi

    Short Communications Pages: 625 - 627

20. Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers

    • T. Hedner
    • J. Hedner
    • J. Heykants

    Short Communications Pages: 629 - 631

21. Lack of defect in oxidative hydroxylation of debrisoquine in a patient with halothane hepatitis

    • M. Toutoungi
    • D. Magnenat

    Letter To The editors Pages: 633 - 634